Inhibrx Biosciences
Utility Patents

Last updated:

List of all Inhibrx Biosciences patents 10 in total

Status Patent
Grant
Utility: CD123-binding polypeptides and uses thereof External link
Filling date: 6 Sep 2025 Issue date: 6 Sep 2022
Grant
Utility: PD-1 single domain antibodies and therapeutic compositions thereof External link
Filling date: 6 Sep 2025 Issue date: 28 Dec 2021
Grant
Utility: Multivalent and multispecific DR5-binding fusion proteins and methods of treating neoplasms External link
Filling date: 6 Sep 2025 Issue date: 14 Sep 2021
Grant
Utility: Multivalent and multispecific OX40-binding fusion proteins External link
Filling date: 6 Sep 2025 Issue date: 14 Sep 2021
Grant
Utility: Multivalent and multispecific glucocorticoid-induced TNFR-related protein (GITR)-binding single-domain antibody fusion proteins and encoding nucleic acids External link
Filling date: 6 Sep 2025 Issue date: 24 Nov 2020
Grant
Utility: Type III secretion system targeting molecules External link
Filling date: 6 Sep 2025 Issue date: 18 Aug 2020
Grant
Utility: Serpin fusion polypeptides and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 4 Aug 2020
Grant
Utility: Serpin fusion polypeptides and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 28 Jul 2020
Grant
Utility: Non-immunogenic single domain antibodies External link
Filling date: 6 Sep 2025 Issue date: 7 Jan 2020
Grant
Utility: Multivalent and multispecific 41BB-binding fusion proteins External link
Filling date: 6 Sep 2025 Issue date: 10 Dec 2019

Showing 1 to 10 of 10 patents.